Arrowhead Pharmaceuticals (ARWR) reported a fiscal Q1 net loss late Monday of $1.39 per diluted share, wider than a $1.24 loss a year earlier.
Analysts polled by FactSet expected a loss of $0.41.
Revenue for the quarter ended Dec. 31 was $2.5 million, compared with $3.6 million a year earlier.
Analysts polled by FactSet expected $72.8 million.
Shares of the company fell 1.9% in recent after-hours activity.
Price: 19.55, Change: -0.37, Percent Change: -1.86
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。